Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Receivables - Net (2019 - 2025)

Historic Receivables - Net for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $9.1 million.

  • AVITA Medical's Receivables - Net fell 2290.85% to $9.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 million, marking a year-over-year decrease of 2290.85%. This contributed to the annual value of $9.1 million for FY2025, which is 2290.85% down from last year.
  • AVITA Medical's Receivables - Net amounted to $9.1 million in Q4 2025, which was down 2290.85% from $9.0 million recorded in Q3 2025.
  • AVITA Medical's Receivables - Net's 5-year high stood at $12.0 million during Q1 2025, with a 5-year trough of $2.2 million in Q1 2021.
  • Over the past 5 years, AVITA Medical's median Receivables - Net value was $5.8 million (recorded in 2023), while the average stood at $6.5 million.
  • In the last 5 years, AVITA Medical's Receivables - Net skyrocketed by 11803.7% in 2023 and then crashed by 2290.85% in 2025.
  • Quarter analysis of 5 years shows AVITA Medical's Receivables - Net stood at $3.1 million in 2021, then increased by 12.73% to $3.5 million in 2022, then soared by 118.04% to $7.7 million in 2023, then skyrocketed by 53.78% to $11.8 million in 2024, then fell by 22.91% to $9.1 million in 2025.
  • Its Receivables - Net stands at $9.1 million for Q4 2025, versus $9.0 million for Q3 2025 and $11.3 million for Q2 2025.